Drug Infusion Systems Market Size to Reach Valuation of USD 18.17 Billion in 2028 | Asia Pacific is Expected to Register Significant Growth due to Increasing Prevalence of Diabetes and Cancer, says Emergen Research

The global drug infusion systems market size reached USD 10.56 Billion in 2020 and is expected to register a CAGR of 7.1% during the forecast period, according to latest analysis by Emergen Research. Rising prevalence of diabetes globally is expected to drive global drug infusion systems market revenue growth to a significant extent during the forecast period. Increasing demand for drug infusion systems to control hemodynamics is expected to further augment market growth over the forecast period. Rising demand for drug infusion systems to reduce chances of medication errors, especially on pediatric patients, is expected to boost global drug infusion systems market revenue growth over the forecast period.

However, high cost of drug infusion systems is expected to hamper global drug infusion systems market growth to some extent during the forecast period.

Click Here to Access Free sample PDF Copy of the Report@ https://www.emergenresearch.com/request-sample/692

Some Key Highlights From the Report

  • Increasing usage of closed-loop systems to automate drug infusion to control hemodynamics is driving revenue growth of the closed-loop system segment, which is expected to register a significantly rapid CAGR over the forecast period.
  • The total parenteral nutrition segment is expected to register significant revenue growth over the forecast period due to increasing use of total parenteral nutrition type of infusion in pediatric patients for feeding and delivering other fluid nutrients through the vein.
  • The enteral segment is expected to register significant revenue growth over the forecast period due to rising utilization of the enteral route for pediatrics and nutrition applications.
  • The hospital segment is expected to register significant revenue growth over the forecast period due to increasing application of drug infusion systems in hospitals for the controlled delivery of drugs and fluids.
  • Asia Pacific is expected to register fastest revenue growth rate during the forecast period due to rising investment by governments for adoption of technologically advanced medical equipment in the healthcare industry in countries in the region.
  • Key players in the market include Medtronic plc, Arcomed Ag, Baxter International Inc., Insulet Corporation, Smiths Group plc, Becton, Dickinson and Company, Halyard Health, Inc., ICU Medical, Inc., Flowonix Medical Inc., Zyno Medical LLC
  • In November 2019, ICU Medical, Inc. announced the acquisition of Pursuit Vascular, Inc. for USD 75.0 million, with an additional earnout payment reportedly coming in 2021. Pursuit Vascular's ClearGuard HD is a natural extension to ICU Medical's needle-free IV connector and other infection control technologies, leading to best-of-breed solutions.

Make Payment [Buy your Exclusive copy]@ https://www.emergenresearch.com/select-license/692

Emergen Research has segmented the global drug infusion systems market on the basis of control systems, infusion type, administration route, application, end-use, and region:

  • Control Systems Outlook (Revenue, USD Billion; 2018–2028)
  • Infusion Type Outlook (Revenue, USD Billion; 2018–2028)
    • Continuous Infusion
    • Intermittent Infusion
    • Patient Controlled Infusion
    • Total Parenteral Nutrition
  • Administration Route Outlook (Revenue, USD Billion; 2018–2028)
    • Enteral
    • Subcutaneous
    • Intravenous
    • Arterial
    • Epidural
  • Application Outlook (Revenue, USD Billion; 2018–2028)
    • Pediatrics
    • Diabetes
    • Nutrition
    • Hematology
    • Analgesia
    • Chemotherapy
    • Others
  • End-Use Outlook (Revenue, USD Billion; 2018–2028)

Have a look at Report Description and Table of Contents of Market Report@ https://www.emergenresearch.com/industry-report/drug-infusion-systems-market

  • Regional Outlook (Revenue, USD Billion; 2018–2028)
    • North America
      1. U.S.
      2. Canada
      3. Mexico
    • Europe
      1. Germany
      2. France
      3. U.K.
      4. Italy
      5. Spain
      6. BENELUX
      7. Rest of Europe
    • Asia Pacific
      1. China
      2. India
      3. Japan
      4. South Korea
      5. Rest of APAC
    • Latin America
      1. Brazil
      2. Rest of LATAM
    • Middle East & Africa
      1. Saudi Arabia
      2. UAE
      3. South Africa
      4. Turkey
      5. Rest of MEA

Explore our reports from Healthcare Catogory:

Blood Pressure Monitoring Devices Market By Product Type (Sphygmomanometer, Digital Blood Pressure Monitor, Ambulatory Blood Pressure Monitor, Instruments & Accessories, Transducers) By Technology (Air Pressure-based, Sensor-based), By End-Use (Hospitals and Clinics, Ambulatory Surgical Centers, Diagnostic Centers, Homecare Settings, Others), and By Region

Wearable Injectors Market By Technology (Motor-driven. Spring-based), By Type (Off-body, On-body), By Application (Cardiovascular Disease, Diabetes, Immuno-oncology), By End-use (Hospitals, Home Care Settings), and By Region, Forecast to 2028

Oncolytic Virus Therapy Market By Type (Monoclonal Antibodies, Checkpoint Inhibitors, Cancer Vaccines, Immunomodulators), By Application (Melanoma, Lung Cancer, Breast Cancer), By End-Use (Hospitals, Clinics, Research Institutes), and By Region, Forecast to 2028

Electrotherapy Market By Treatment Type (Transcutaneous Spinal Electro analgesia (TSE), Interferential Current Therapy (IC), Pulsed Short Wave Diathermy (PSWD), Transcutaneous Electrical Nerve Stimulation (TENS), Spinal Cord Stimulation (SCS), Electro-Acupuncture (EA), Percutaneous Electrical Nerve Stimulation (PENS), Others), By Application (Sports Injury, Neuromuscular Dysfunction, Tissue Repair, Urine and Fecal Incontinence, Iontophoresis, Pain Management, Acute and Chronic Edema), By End-Use (Rehabilitation Centers, Long-term Care Centers, Clinics Hospitals, Others), By Region

Tumor Genomics Market By Technique Next Generation Sequencing Technique (NGS), Polymerase Chain Reaction (PCR), Microarray, In-Situ Hybridization (ISH), Immunohistochemistry (ICH), Others (Mass Spectrometry and Flow Cytometry), By Application: Diagnostics and Monitoring, Drug Discovery and Development, Biomarker Discovery, By End use: Academics and Research Organizations, Hospitals and Ambulatory Clinics, Clinical and Diagnostic Laboratories, Biotechnology and Pharmaceutical Companies, By Region, Forecast to 2028

About Emergen Research

Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Emergen Research has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.

Contact Us:

Eric Lee

Corporate Sales Specialist

Emergen Research | Web: www.emergenresearch.com

Direct Line: +1 (604) 757-9756

E-mail: sales@emergenresearch.com

Facebook | LinkdIn | Twitter | Blogs

Read Full Press Release@ https://www.emergenresearch.com/press-release/global-drug-infusion-systems-market

Back to news